I. Technical Specifications
- Components: CJC-1295 No DAC (C_152H_252N_44O_42) and Ipamorelin (C_38H_49N_9O_5)
- Ratio: 1:1
- Appearance: White Lyophilized Powder
- Solubility: Highly soluble in Bacteriostatic Water or Sterile Water
II. Compound Overview
The CJC-1295 / Ipamorelin Blend
is engineered to bypass the limitations of single-peptide protocols. CJC-1295 (Mod GRF 1-29)
acts as a Growth Hormone Releasing Hormone (GHRH) mimetic, providing the “signal” for the pituitary to produce GH. Ipamorelin
acts as a Ghrelin mimetic and Growth Hormone Releasing Peptide (GHRP), providing the “pulse” to release that GH while simultaneously suppressing Somatostatin (the hormone that inhibits GH). Together, they create a physiological surge of Growth Hormone that mimics the body’s natural 24-hour rhythm. Taurus Peptides provides this blend in a precision-measured format to ensure consistent data in metabolic and endocrine research.
III. Mechanism of Action (The “Science” Section)
Current literature suggests the blend operates through reversal of the somatopause signaling chain
:
- GHRH Pathway (CJC-1295): It binds to GHRH receptors on the pituitary, increasing the total amount of Growth Hormone available for secretion. By using the “No DAC” version, researchers ensure a short half-life (~30 minutes), which prevents “GH bleed” and maintains natural pulsatility.
- GHRP Pathway (Ipamorelin): It binds to the Growth Hormone Secretagogue Receptor (GHSR). This is critical because it triggers the immediate release (the “pulse”) of the GH stores created by the CJC-1295.
[Diagram of GHRH and GHRP synergy on the Somatotroph cell]
Unlike older GHRPs (like Hexarelin or GHRP-6), Ipamorelin is highly selective
. Researchers observe that it does not significantly increase hunger (ghrelin response), nor does it cause spikes in Cortisol or Prolactin
. This allows for a “clean” endocrine profile during long-term research studies.
IV. Observed Research Outcomes
- Lipid Metabolism: Studies observed a significant increase in fat oxidation and a reduction in adipose tissue, particularly in the abdominal region.
- Skeletal Muscle Integrity: Research indicates improved nitrogen retention and protein synthesis, leading to higher lean muscle mass in animal models.
- Enhanced Recovery Architecture: When evaluated in sleep and recovery studies, the blend was found to improve the depth of Slow Wave Sleep, the phase where the majority of physiological repair occurs.
V. Storage & Handling
- Storage: Store at -20^\circ C for long-term stability. Once reconstituted, store at 4^\circ C and use within 14 days.
- Handling: Do not shake. Both peptides are relatively stable, but the 1:1 blend should be handled with care to prevent denaturation of the amino acid chains. Reconstitute with a sterile, pH-neutral diluent like Bacteriostatic Water and swirl gently until the solution is completely clear.
